扶他林双氯芬酸二乙胺乳胶剂2%
Search documents
 京东健康X赫力昂战略签约 助力疼痛管理生态建设
 Ren Min Wang· 2025-04-26 01:30
 Core Insights - The collaboration between JD Health and Heron aims to enhance pain management services in China, leveraging JD Health's digital healthcare capabilities and Heron's expertise in pain management [1][2][3] - The partnership will focus on creating a comprehensive health service system that covers prevention, diagnosis, treatment, and rehabilitation for pain management [1][3]   Group 1: Strategic Collaboration - JD Health and Heron have signed a strategic cooperation agreement to work on three main areas: public education, product promotion, and medical services, utilizing digital methods and innovative models [3] - The collaboration is positioned as an initiative to support the "Healthy China 2030" strategy, aiming to improve national awareness of pain management and contribute to the overall health of the population [3]   Group 2: Event Highlights - The signing ceremony included a "Pain-Free Workday" event featuring interactive educational activities, such as pain management quizzes and posture assessments, aimed at raising public awareness [2] - New innovative pain relief products, including Ibuprofen soft capsules and Diclofenac emulsion, were launched during the event to provide effective solutions for various pain scenarios [2]   Group 3: Expert Insights - Dr. Zhao Ying, a pain management specialist, emphasized the urgency of improving pain management experiences through public education and diverse solutions [2]